Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/58831| Title: | Role of anti-mullerian hormone in patients with polycystic ovarian syndrome |
| Authors: | Fava, A. Brincat, Mark Calleja-Agius, Jean |
| Keywords: | Ovaries -- Cysts Polycystic ovary syndrome Glycoprotein hormones |
| Issue Date: | 2013 |
| Publisher: | CIC Edizioni Internazionali |
| Citation: | Fava, A., Brincat, M., & Calleja-Agius, J. (2013). Role of anti-mullerian hormone in patients with polycystic ovarian syndrome. Giornale Italiano di Ostetricia e Ginecologia, 35(1), 203-205. |
| Abstract: | Anti-mullerian hormone (AMH) is a glycoprotein which belongs to the transforming growth factor (TGF)β family. It is expressed mainly by the granulosa cells of the preantral and small antral follicles in females. It is measured using a single unified assay produced by Beckman Coulter; values are however interpreted according to reference ranges of individual laboratories. The role of AMH is to delay recruitment of primordial follicles and to diminish sensitivity of the growing follicles to follicle stimulating hormone. Decreased levels of AMH suggest a reduced antral follicle pool and thus ovarian reserve (1). Increased levels of AMH are found in polycystic ovary (PCO) (2) /polycystic ovarian syndrome (PCOS) patients (1). High AMH level is associated with various clinical and biochemical characteristics. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/58831 |
| ISSN: | 03919013 |
| Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Role_of_anti-mullerian_hormone_in_patients_with_polycystic_ovarian_syndrome_2013.pdf Restricted Access | 596.91 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.